Co-Therapy of Albendazole and Dexamethasone Reduces Pathological Changes in the Cerebral Parenchyma of Th-1 and Th-2 Dominant Mice Heavily Infected with Angiostrongylus cantonensis: Histopathological and RNA-seq Analyses

Administration of albendazole alone was not very suitable for the treatment of cerebral angiostrongyliasis. This study was designed to evaluate the effects of the co-therapy of this drug and dexamethasone in Th-1 and Th-2 dominant mice infected with Angiostrongylus cantonensis. Each of BALB/c and C5...

Descripción completa

Detalles Bibliográficos
Autores principales: Jhan, Kai-Yuan, Cheng, Chien-Ju, Jung, Shih-Ming, Lai, Yi-Jen, Chen, Kuang-Yao, Wang, Lian-Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067505/
https://www.ncbi.nlm.nih.gov/pubmed/33917604
http://dx.doi.org/10.3390/biom11040536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067505/
https://www.ncbi.nlm.nih.gov/pubmed/33917604
http://dx.doi.org/10.3390/biom11040536

Ejemplares similares